RecruitingPhase 3NCT07365995
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Sponsor: BioNTech SE
Niles, IL · Peoria, IL · +19 more sites
1 recruiting prostate cancer studies with a site in Niles, IL.
Sponsor: BioNTech SE
Niles, IL · Peoria, IL · +19 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.